The Viral Vector Core Facility announces a new collaboration with The Michael J. Fox Foundation in its continued research into Parkinson’s disease. The core facility will produce viral vectors — a means of delivering genetic material into cells — as well as provide a repository and virus distribution plan to the foundation.
View new AAV products for distribution on behalf of our Michael J. Fox Foundation collaboration.